Earth Science Tech, Inc. (ETST) “Positioned to C
Post# of 333
(Total Views: 197)
Posted On: 11/13/2018 4:43:09 PM
Earth Science Tech, Inc. (ETST) “Positioned to Compete” in CBD Market that’s Projected to Reach $2.1B by 2020, Per SeeThruEquity
- SeeThruEquity, LLC, in coverage update, projects that ETST will reach $7.1 million in sales in FY2020 as it grows its product line and expands into full spectrum cannabinoid beverages
- ETST’s ‘As Seen On TV’ campaign, with television celebrity Kevin Harrington as spokesperson, is expected to help drive company sales in the CBD market to $2.2 million by FY2019
- Leading factors in forecast growth include company’s targeting of a fast-growing sub-segment of the market in hemp-derived CBD, as well as the expanded retail distribution of its product line, according SeeThruEquity research
Earth Science Tech, Inc. (OTCQB: ETST) is seen by research firm SeeThruEquity as having diverse capabilities that will generate its growth in the rapidly expanding CBD market, which is projected by Hemp Business Journal to reach $2.1 billion by 2020 from $202 million in 2017, with $450 million of that increase coming from hemp-based sources, according to Forbes (http://nnw.fm/i8Fi3).
SeeThruEquity sees ETST’s participation in this booming industry, focusing on the hemp-derived segment, as key to it reaching volume of $7.1 million in sales by FY2020. The research report described its diversity, including its line of nutraceuticals and pharmaceuticals, TV campaign and uplisting to the OCTQB market, and calls Harrington a “potential catalyst” for sales (http://nnw.fm/c6G2H).
“ETST appears positioned to compete for its share of this market growth,” the report said, “as the company has established broad distribution for its high purity CBD product line, covering more than 90,000 retail outlets. Moreover, the company’s pipeline remains robust with an upcoming direct-to-consumer campaign with ‘As Seen On TV’ as well as planned pharmaceutical products in coming years, funding permitting.”
ETST is a biotech company based in Doral, Florida, marketing and developing CBD products, as well as dietary supplements for the pharmaceutical and nutraceutical fields. The company is focused on the cannabidiol, pharmaceutical and nutraceutical sectors, as well as the development, through subsidiaries, of medical devices and research. ETST’s goal is to become a world leader in the CBD space.
It is also moving ahead with the development of its Hygee medical device, finalizing an agreement with Groupe Opmedic, Inc. and its Procrea Fertility Laboratories for lab services to detect sexually transmitted infections (STIs) in women using Hygee (http://nnw.fm/3Q8ko).
In the CBD market, ETST is in discussions with an organic grower and processor for an exclusive business/supply relationship that could offer the company its outdoor organic industrial hemp plants, mixing, extraction, bottling and packaging on an exclusive basis. The proposed deal would give ETST a consistent industrial hemp source (http://nnw.fm/GQs46).
ETST holds several wholly owned subsidiaries. Cannabis Therapeutics is an emerging biotechnology company. KannaBidioiD manufactures and distributes in the recreational sector. Earth Science Foundation, Inc. is becoming a non-profit and accepts grants and donations to conduct additional studies. Earth Science Pharmaceutical develops medical diagnostic tools and vaccines. It also formed subsidiary Canno Inno Laboratories Inc., a strategic Montreal, Canada-based company that provides ETST with access to government grants.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- SeeThruEquity, LLC, in coverage update, projects that ETST will reach $7.1 million in sales in FY2020 as it grows its product line and expands into full spectrum cannabinoid beverages
- ETST’s ‘As Seen On TV’ campaign, with television celebrity Kevin Harrington as spokesperson, is expected to help drive company sales in the CBD market to $2.2 million by FY2019
- Leading factors in forecast growth include company’s targeting of a fast-growing sub-segment of the market in hemp-derived CBD, as well as the expanded retail distribution of its product line, according SeeThruEquity research
Earth Science Tech, Inc. (OTCQB: ETST) is seen by research firm SeeThruEquity as having diverse capabilities that will generate its growth in the rapidly expanding CBD market, which is projected by Hemp Business Journal to reach $2.1 billion by 2020 from $202 million in 2017, with $450 million of that increase coming from hemp-based sources, according to Forbes (http://nnw.fm/i8Fi3).
SeeThruEquity sees ETST’s participation in this booming industry, focusing on the hemp-derived segment, as key to it reaching volume of $7.1 million in sales by FY2020. The research report described its diversity, including its line of nutraceuticals and pharmaceuticals, TV campaign and uplisting to the OCTQB market, and calls Harrington a “potential catalyst” for sales (http://nnw.fm/c6G2H).
“ETST appears positioned to compete for its share of this market growth,” the report said, “as the company has established broad distribution for its high purity CBD product line, covering more than 90,000 retail outlets. Moreover, the company’s pipeline remains robust with an upcoming direct-to-consumer campaign with ‘As Seen On TV’ as well as planned pharmaceutical products in coming years, funding permitting.”
ETST is a biotech company based in Doral, Florida, marketing and developing CBD products, as well as dietary supplements for the pharmaceutical and nutraceutical fields. The company is focused on the cannabidiol, pharmaceutical and nutraceutical sectors, as well as the development, through subsidiaries, of medical devices and research. ETST’s goal is to become a world leader in the CBD space.
It is also moving ahead with the development of its Hygee medical device, finalizing an agreement with Groupe Opmedic, Inc. and its Procrea Fertility Laboratories for lab services to detect sexually transmitted infections (STIs) in women using Hygee (http://nnw.fm/3Q8ko).
In the CBD market, ETST is in discussions with an organic grower and processor for an exclusive business/supply relationship that could offer the company its outdoor organic industrial hemp plants, mixing, extraction, bottling and packaging on an exclusive basis. The proposed deal would give ETST a consistent industrial hemp source (http://nnw.fm/GQs46).
ETST holds several wholly owned subsidiaries. Cannabis Therapeutics is an emerging biotechnology company. KannaBidioiD manufactures and distributes in the recreational sector. Earth Science Foundation, Inc. is becoming a non-profit and accepts grants and donations to conduct additional studies. Earth Science Pharmaceutical develops medical diagnostic tools and vaccines. It also formed subsidiary Canno Inno Laboratories Inc., a strategic Montreal, Canada-based company that provides ETST with access to government grants.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Earth Science Tech, Inc. (ETST) Stock Research Links
Scroll down for more posts ▼